Cancer & Hematology Centers of Western Michigan’s Eric Santos, MD, recently spoke to Clinical Oncology News about its ongoing Prospective Clinico-Genomic study. The study, which examines how “various technologies… can be integrated to streamline and simplify clinical trials for people with advanced lung cancer,” was presented at the International Association for the Study of Lung Cancer (IASLC) 2021 World Congress on Lung Cancer.
“The ability to use real-world data across many sites has the potential to change how clinical trials are done,” Dr. Santos told Clinical Oncology News. “Valuable information is now being made available for analysis that may have a huge impact on our understanding on how best to manage these malignancies.”
To read Clinical Oncology News‘ full article, click here.
Founded in 1979, CHCWM has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families. Thanks to the hard work of our growing staff, CHCWM has been named one of the Nation’s Best and Brightest Companies to Work For®. To learn more about CHCWM, visit chcwm.com.
Becky Downing, Social Media & Marketing Specialist